Randomized Phase Ill Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer | NYU Langone Health

Go Back to All Clinical Trials

Randomized Phase Ill Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Breast Cancer
Age: Between 18 years - 100 years
Gender: Male or Female

Other Inclusion Criteria:

1) Patients who have invasive breast cancer within the past 12 months and must have stage II or III breast cancer. 2) Patients who have no history of other malignancy within past 4 years and no comorbid conditions that would cause life expectancy of less than 5 years.

You may not be eligible for this study if the following are true:

1) Patients who have diabetes mellitus currently being treated with insulin or sulfonylurea drugs.